Bryostatin 1: Will the oceans provide a cancer cure?

Journal of the National Cancer Institute

Volumn 85, Issue 22, 1993, Pages 1790-1793

  Kraft, Andrew S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRYOSTATIN 1; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 6; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; BRYOZOA; CANCER INHIBITION; CELL DIFFERENTIATION; DEGRANULATION; DRUG MECHANISM; DYSPNEA; EDITORIAL; ENZYME ACTIVATION; HORMONE RELEASE; HUMAN; LEUKEMIA CELL; MYALGIA; NONHUMAN; PHLEBITIS; PRIORITY JOURNAL; RETICULOSARCOMA; SEA; THROMBOCYTE COUNT;

ANTINEOPLASTIC AGENTS; HUMAN; LACTONES; NEOPLASMS; OCEANS AND SEAS;

EID: 0027488490     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/85.22.1790     Document Type: Editorial

References (30)

1. Pettit G, Kamano Y, Aoyagi R, et al: Antineoplastic agents 100. The marine bryozoan Amathta covoluta. Tetrahedron 41:985-994, 1985
2. Pettit GR, Herald CL, Doubek DL, et al: Isolation and structure of bryostatin 1. J Am Chem Soc 104:6846-6848, 1982
3. Prendiville J, Crowther D, Thatcher N, et al: A phase I study of intravenous bryostatin 1 in patients with advanced cancer. Br J Cancer 68:418-425, 1993
4. Philip PA, Rea D, Thavasu P, et al: Phase 1 study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor a induction in vivo. J Natl Cancer Inst 85:1812-1818, 1993
5. Baer JC, Slack JA, Pettit GR: Stability-indicating high-performance liquid chromatography assay for the anticancer drug bryostatin 1 J Chromatogr 467:332-335, 1989
6. Kraft AS, Smith JB, Berkow RL: Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester- induced differentiation of human promyelocytic leukemia cells, HL-60. Proc Natl Acad Sci U S A 83:1334-1338, 1986
7. Stone RM, Sanban E, Pettit GR, et al: Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells. Blood 72:208-213, 1988
8. Fields AP, Pincus SM, Kraft AS, et al: lnterleukin-3 and bryostatin 1 mediate rapid nuclear envelope protein phosphorylation in growth factor-dependent FDC-P1 hematopoietic cells. A possible role for nuclear protein kinase C. J Biol Chem 264:21896-21901, 1989
9. Kraft AS, Reeves JA, Ashendel CL: Differing modulation of protein kinase C by bryostatin 1 and phorbol esters in JB6 mouse epidermal cells. J Biol Chem 263 8347-8442, 1988
10. Nishizuka Y: The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308:693-698, 1984
11. Blumberg PM: Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture. Cancer Res 48:1-8, 1988
12. Jalava AM, HeikkilS J, Akerlind G, et al: Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells. Cancer Res 50:3422-3428, 1990
13. Housey GM, Johnson MD, Hsiao W-LW, et al: Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 52:343-354, 1988
14. Lilly M, Tompkins C, Brown C, et al: Differentiation and growth modulation of chronic myelogenous leukemia cells by bryostatin. Cancer Res 50:5520-5525, 1990
15. Lilly M, Brown C, Pettit G, et al: Bryostatin 1: a potential antileukemic agent for chronic myelomonocytic leukemia. Leukemia 5:283-287, 1991
16. Kraft AS, Williams F, Pettit GR, et al: Varied differentiation responses of human leukemias to bryostatin 1. Cancer Res 49:1287-1293, 1989
17. Drexler HG, Gignac SM, Jones RA, et al: Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells. Blood 74:1747-1757, 1989
18. Tallant EA, Smith JB, Wallace RW: Bryostatins mimic the effects of phorbol esters in intact human platelets. Biochim Biophys Acta 929:40-46, 1987
19. Berkow RL, Kraft AS: Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol receptor. Biochem Biophys Res Commun 131:1109-1116, 1985
20. May WS, Sharkis SJ, Esa AH, et al: Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells. Proc Natl Acad Sci U S A 84:8483-8487, 1987
21. Pasti G, Rivedal E, Yuspa SH, et al: Contrasting duration of inhibition of cell-cell communication in primary mouse epidermal cells by phorbol 12, 13-dibutyrate and by bryostatin 1. Cancer Res 48:447-451, 1988
22. Jetten AM, George MA, Pettit GR, et al: Effects of bryostatins and retinoic acid on phorbol ester- and diacylglycerol-induced squamous differentiation in human tracheobronchial epithelial cells. Cancer Res 49:3990-3995, 1989
23. Dale IL, Bradshaw TD, Gescher A, et al: Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol- 13-acetate on protein kinase C activity in A549 human lung carcinoma cells. Cancer Res 49:3242-3245, 1989
24. Kennedy MJ, Prestigiacomo LJ, Tyler G, et al: Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines. Cancer Res 52:1278-1283, 1992
25. Grant S, Pettit GR, McCrady C: Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM). Exp Hematol 20:34-42, 1992
26. Basu A, Lazo JS: Sensitization of human cervical carcinoma cells to cu-diamminedichloroplatinum(Il) by bryostatin 1. Cancer Res 52:3119-3124, 1992
27. Mohr H, Pettit GR, Plessing-Menze A: Co-induction of lymphokine synthesis by the antineoplastic bryostatins. Immunobiology 175:420-430, 1987
28. Hess AD, Silanskis MK, Esa AH, et al: Activation of human T lymphocytes by bryostatin J Immunol 141 3263—3269, 1988
29. Trenn G, Pettit GR, Takayama H, et al: Immunomodulating properties of a novel series of protein kinase C activators. The bryostatins. J Immunol 140:433-439, 1988
30. Tuttle TM, Inge TH, Bethke KP, et al: Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1. Cancer Res 52:548-553, 1992